Angiogenesis factors and preeclampsia

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nature Medicine

• Publication date

  2008-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm1108-1187PMID 18989301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia

  2008cited by this paper
• Soluble endoglin contributes to the pathogenesis of preeclampsia

  2006cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

  2006cited by this paper
• 2-Methoxyestradiol-induced Apoptosis in Prostate Cancer Cells Requires Smad7*

  2005cited by this paper
• Pre-eclampsia

  2005cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• Antibiotic use in relation to the risk of breast cancer

  2004cited by this paper
• Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

  2003cited by this paper
• Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.

  1999cited by this paper
• Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.

  1994cited by this paper

• Maternal plasma microRNA signatures for early detection of early-onset preeclampsia.

  2025cites this paper
• NFĸB and its inhibitors in preeclampsia: mechanisms and potential interventions

  2025cites this paper
• Immunometric and functional measurement of endogenous vasoinhibin in human sera

  2023cites this paper
• Pre-eclampsia: does cardiac function differ in HIV-positive and -negative women?

  2023cites this paper
• A blood-based miRNA signature for early non-invasive diagnosis of preeclampsia

  2022cites this paper
• Correlation between Level of Soluble Endoglin and Soluble FMS- Like Tyrosine Kinase-1 on Severe Preeclampsia and Normal Pregnancy

  2021cites this paper
• INVESTIGATION OF SFLT-1 AND VEGF EXPRESSION IN NORMOTENSIVE AND PREECLAMPTIC PLACENTA. AN IMMUNOHISTOCHEMICAL STUDY

  2020cites this paper
• Hypertonie in der Schwangerschaft

  2020cites this paper
• Tetramethylpyrazine reduces the consequences of nitric oxide inhibition in pregnant rats

  2019cites this paper
• Associations Between Neurocognitive Characteristics, Treatment Outcome, and Dropout Among Aggressive Forensic Psychiatric Outpatients

  2018cites this paper
• Increased oxidative damage and premature placental aging contribute to the aetiology of stillbirth

  2018cites this paper
• Vascular responses of aortic, renal, and uterine arteries in suramin-induced preeclampsia-like syndrome in rats

  2018cites this paper
• Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors

  2018cites this paper
• Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib‐induced Hypertension in Metastatic Renal Cell Carcinoma

  2017cites this paper
• [Side effect management of tyrosine kinase inhibitors in urology : Hypertension].

  2016cites this paper
• Nebenwirkungsmanagement von Tyrosinkinaseinhibitoren in der Urologie

  2016cites this paper
• Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group

  2016influential citation
• Nebenwirkungsmanagement von Tyrosinkinaseinhibitoren in der Urologie

  2016cites this paper
• Placental exosomes and pre-eclampsia: Maternal circulating levels in normal pregnancies and, early and late onset pre-eclamptic pregnancies.

  2016cites this paper
• Hypertonie in der Schwangerschaft

  2015cites this paper
• Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy

  2015cites this paper
• Understanding Toxicities of Targeted Agents: Implications for Anti-tumor Activity and Management.

  2015cites this paper
• The Level of Soluble FMS-Like Tyrosinkinase-1, Placental Growth Factor and Vitamin E in Pre-Eclampsia and Normotensive Pregnancy

  2015cites this paper
• Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients

  2015influential citation
• The role of microRNAs on angiogenesis and vascular pressure in preeclampsia: The evidence from systematic review

  2015cites this paper
• The role of shed placental DNA in the systemic inflammatory syndrome of preeclampsia.

  2015cites this paper
• Differential expressions of stromal cell-derived factor-1α and vascular endothelial growth factor in the placental bed of pregnancies complicated by preeclampsia

  2014cites this paper
• Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms.

  2014cites this paper
• Corin Mutations K317E and S472G from Preeclamptic Patients Alert Zymogen Activation and Cell Surface Targeting*

  2014cites this paper
• Antenatal Corticosteroids Impact the Inflammatory Rather Than the Antiangiogenic Profile of Women With Preeclampsia

  2014cites this paper
• Der automatisierte Elecsys®-Assay zur Messung von sFlt1, PlGF und ihrem Quotienten sFlt1/PlGF in der Diagnose hypertensiver Schwangerschaftserkrankungen

  2014cites this paper
• Glycogen Phosphorylase Isoenzyme BB Plasma Concentration Is Elevated in Pregnancy and Preterm Preeclampsia

  2012cites this paper
• Decreased expressions of vascular endothelial growth factor and visfatin in the placental bed of pregnancies complicated by preeclampsia

  2012cites this paper
• Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

  2011cites this paper
• Maternal Heme Oxygenase 1 Regulates Placental Vasculature Development via Angiogenic Factors in Mice1

  2011cites this paper
• An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia.

  2010cites this paper
• Angiogenesis inhibition and preeclampsia.

  2009cites this paper
• Peptide hormone regulation of angiogenesis.

  2009cites this paper
• Proteomic technologies for prenatal diagnostics: advances and challenges ahead

  2009cites this paper
• SHORT COMMUNICATION: Interleukin‐17 Increased Progesterone Secretion by JEG‐3 Human Choriocarcinoma Cells

  2009cites this paper